Submit an Abstract for CCR East 2027

1. General information

Anyone who registers to attend CCR East 2027 may submit up to 2 abstracts. Accepted abstracts are given as 3-minute poster presentations to faculty-led poster rounding groups.

Residents and fellows may also take part in the NYRIF (North American Young Rheumatology Investigators Forum) symposium, which has its own submission portal at www.nyrif.com. Interesting case studies may be considered for oral presentation in the Thieves’ Market.

2. Requirements for submissions

• The work must describe clinical or basic research related to rheumatology. Case reports are not accepted here, unless submitted by a resident or fellow-in-training through NYRIF.
• Previously published or presented peer-reviewed work (an “encore presentation”) is welcome.
• All posters and presentations must be in English.
• All presenters must be registered attendees of CCR East 2027.
• Abstracts are submitted through this portal and must meet the criteria below. The deadline is the deadline shown in the portal.
• Author information and a signed conflict of interest disclosure (COID) are completed in the portal with the abstract.
• Two investigators may not submit the same study. Submissions are checked for duplication, and abstracts that appear to be versions of a single study will be rejected.
• Choose one category for each abstract. Please review the categories before you start.
• Human research must conform to the principles of the Declaration of Helsinki of the World Medical Association. The Program Committee requires assurances of the responsible use of animals in research, as endorsed by the American Association for the Advancement of Science.

3. Policies for abstracts and poster presentations

• There is a limit of 2 abstracts per attendee.
• Submitting an abstract is a commitment to present a poster of its contents if accepted.
• The submitting author is the presenting author unless another coauthor is appointed to present. Only one presenter is permitted per abstract.
• Tell CCR staff about any change of presenter by a date announced by CCR staff. The new presenter must also be a registered full-symposium attendee. Refunds of the original author’s registration follow CCR’s cancellation policy, and a $100 processing fee applies to a change of presenter.
• Every abstract and poster must contain disclosures, and the COID must be completed with the submission. If you have nothing to disclose, put “No Disclosures” at the end of the abstract. Disclosures must also appear on the poster or be attached to the poster board.
• Registration for the meeting, including the COID, must be complete by a date announced by CCR staff, or the abstract will be rejected.
• The full text of accepted abstracts will be viewable online from a date announced by CCR staff. The program book contains the full text of accepted abstracts with the title, submitting author, and up to two institutions.
• Abstracts are printed exactly as submitted. CCR staff do not edit language, spelling, or grammar; minor formatting changes may be made for the mobile app or the printed program book.
• After the submission deadline the system closes and abstracts go to print. Later changes need administrative approval and will not appear in printed materials.
• To withdraw an abstract after the deadline, write to support@ccrheumatology.com before a date announced by CCR staff. Later withdrawals are accepted, but the abstract may still appear in print.
• Posters are grouped by category for poster rounding. The Program Committee decides the format and order of rounding, and categories may be added, combined, or removed by CCR staff.
• Poster rounding is scheduled for a time announced by CCR staff. CCR may change the time or date if necessary.
• CCR does not reimburse abstract or poster presenters for travel, hotel, or per diem expenses.

4. Preparing your abstract

• Upload the abstract as PDF, Word (.docx), Word 97–2003 (.doc), PowerPoint (.pptx) or PowerPoint 97–2003 (.ppt). The COID is completed and signed online in the portal. A research abstract template and formatting guide are available to download.
• Titles reflect the contents of the abstract in no more than 120 characters (not counting spaces).
• Do not italicize, underline, superscript, subscript, or use all capital letters in the title. Capitalize the first letter of all major words, and don’t end the title with a period.
• Abbreviations are not allowed in the title unless they are well known and standard (for example DNA, TNF, IL-6).
• Drug and device names are generic (for example, “pegloticase” rather than “Krystexxa”). Brand names are not used.
• List authors under the title, with up to two affiliations each. List every author’s complete first and last names, not initials. An author’s name must be spelled the same way on every abstract it appears on. If the presenter is not an author, name them as the presenter under the authors.
• Do not include titles or degrees for the authors, and do not put contact information in the abstract.
• The abstract is no more than 2,500 characters (not counting spaces). The title, author information, references, disclosures, and any graphs, tables, figures, or images don’t count toward it.
• Up to five graphs, tables, figures, or images that help readers understand the abstract may be included. They don’t count toward the length limit, must be part of the abstract itself, and can’t be sent later or separately.
• Single-space the abstract in Times New Roman 12-point. Insert special characters with the Symbol font in Word; other software or fonts can make abstracts unreadable or insert the wrong symbols.
• Structure the abstract into Background, Methods, Results, and Conclusion. The Conclusion states the main clinical implications, significance, or relevance of the study.
• Clarity of expression is considered in review. Check grammar, spelling, and punctuation so the text is readable and represents your work.
• Avoid abbreviations whenever possible. Define each abbreviation the first time it appears: the full term, then the abbreviation in parentheses.
• Use a comma for numbers of 1,000 and above.
• Revisions can be made until a date announced by CCR staff. Changes after that date, including adding or removing authors or changing presenters, will not appear in print and may not appear online or in the app.

5. How to submit in the portal

• Sign in with your email address. No password is needed: we email you a secure sign-in link. New and returning presenters use the same form.
• Residents, fellows and medical students: please submit through the separate NYRIF portal.
• Choose Submit Abstract and follow the steps: event, presenter details, these guidelines, your abstract file, abstract details, the automated guideline checks, the COID, and review and submit.
• You are the presenting author and the only person who receives correspondence from CCR about the abstract.
• Each step saves automatically. A draft isn’t sent to CCR until you click Submit on the last step.
• You’ll receive an email confirming your submission. If it doesn’t arrive within 24 hours, check your junk or spam folder, then contact support@ccrheumatology.com.
• To submit a second abstract, repeat these steps with the new abstract.
• Follow your abstract’s status on your dashboard and watch your email for the decision. If you haven’t heard within 7 days of submitting, check your spam folder, then contact support@ccrheumatology.com.

6. Disclosure policies

• The presenter and lead investigator must include their disclosures on every abstract and poster, and a completed, signed COID must accompany the abstract.
• Presenting authors and lead investigators comply with the ACCME disclosure policy: any relationship and the associated commercial entity must be stated.
• A presenting author may be an employee of a pharmaceutical company, as long as the abstract, poster, and COID accurately state all of the presenter’s relationships with the company.
• Presenters state their disclosures in the abstract and on the poster, and verbally disclose any pertinent conflicts at the start of the presentation. A non-author presenter must be able to speak to the integrity and analysis of the data and confirm it was approved for presentation; the poster still shows the authors’ main conflicts of interest.
• All disclosures from presenting authors and lead investigators must be received by the deadline shown in the portal for an abstract to be considered. Without a completed COID and disclosures, an accepted abstract and poster will be removed from the program.
• Responsibility for meeting any disclosure or nondisclosure requirements rests with the researchers and research sponsors (including academic institutions, commercial entities, and non-profit organizations).
• The presenting author is the sole point of contact for all co-authors. CCR directs co-author questions to the submitter.

7. Poster preparation

• Posters go up at the time announced by CCR staff and stay up for attendees to view until the end of the poster rounding session. Don’t remove a poster before the end of the session, or the responsible party may forfeit future poster submissions. Posters left on the boards or the floor afterwards are discarded.
• Presenters attend their boards during the faculty poster rounding session (a time announced by CCR staff).
• Boards are grouped by subject. A presenter with posters in different categories may not have them side by side; placement is at CCR staff’s discretion.
• Post disclosures somewhere on your poster board. Posters without them will be removed, which may affect future presentations.
• Each board is 4 feet high (121 cm) by 8 feet wide (244 cm), including the frame. We recommend a poster no larger than 3 ft 6 in by 7 ft. Push pins are provided; there is one board per abstract.
• Text should be readable from at least three feet away.
• No audiovisual, projection, or powered computer equipment is permitted in the poster area.
• Presenters print and bring their own posters. CCR does not print posters or pay for printing.

8. Permission and reprints

All abstracts and posters appear online and are printed and distributed at CCR East 2027. Poster rounding sessions are recorded and available online to registrants. Make sure every permission needed for publication is in place before you submit.

The meeting is a private event. Programs presented are for the education of attendees and purchasers of recorded presentations as authorized by CCR. The information and materials displayed and presented are the property of CCR and the presenter and may not be photographed, copied, transformed to electronic format, reproduced, or distributed without the written permission of the Congress of Clinical Rheumatology and the presenter. Commercial use of program content without CCR’s written consent is prohibited, before, during, and after the meeting.

9. Style templates

Download a Word template, write your abstract into it, and upload it in the portal.

• Research abstract templateBackground, Methods, Results, Conclusions, References, Disclosures and Figures, ready to fill in.
• Abstract formatting guideFonts, sizes and section limits for each part of the abstract.